Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL.
暂无分享,去创建一个
J. Bell | A. McMichael | G. Screaton | J. Mongkolsapaya | A. Cowper | X. Xu | G. Morris
[1] J. Bell,et al. TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL , 1997, Current Biology.
[2] R. Gentz,et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. , 1997, Science.
[3] W I Wood,et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.
[4] Margot Thome,et al. Inhibition of death receptor signals by cellular FLIP , 1997, Nature.
[5] R. Johnson,et al. Upregulation of Fas Ligand by Simian Immunodeficiency Virus—A nef-arious Mechanism of Immune Evasion? , 1997, The Journal of experimental medicine.
[6] A. McMichael,et al. Evasion of Cytotoxic T Lymphocyte (CTL) Responses by Nef-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells , 1997, The Journal of experimental medicine.
[7] J. Bell,et al. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[8] Arul M. Chinnaiyan,et al. The Receptor for the Cytotoxic Ligand TRAIL , 1997, Science.
[9] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[10] K. Bauer,et al. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB , 1996, Current Biology.
[11] P. Finn,et al. Fas modulation of apoptosis during negative selection of thymocytes. , 1996, Immunity.
[12] J. Young,et al. CAR1, a TNFR–Related Protein, Is a Cellular Receptor for Cytopathic Avian Leukosis–Sarcoma Viruses and Mediates Apoptosis , 1996, Cell.
[13] D. Goeddel,et al. A death-domain-containing receptor that mediates apoptosis , 1996, Nature.
[14] J. Tschopp,et al. Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape , 1996, Science.
[15] S R Sprang,et al. Structures of the extracellular domain of the type I tumor necrosis factor receptor. , 1996, Structure.
[16] A. Chinnaiyan,et al. Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95 , 1996, Science.
[17] K. Bauer,et al. Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA , 1996, Current Biology.
[18] S. Marsters,et al. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.
[19] N. Yoshida,et al. Enhanced and accelerated lymphoproliferation in Fas-null mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[20] C A Smith,et al. Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.
[21] John Calvin Reed,et al. FAP-1: a protein tyrosine phosphatase that associates with Fas. , 1995, Science.
[22] Takashi Suda,et al. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family , 1993, Cell.
[23] B. Barres,et al. Programmed cell death and the control of cell survival: lessons from the nervous system. , 1993, Science.
[24] D. Banner,et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.
[25] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[26] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[27] J. Tschopp,et al. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). , 1997, Immunity.